329 results
Page 5 of 17
8-K
EX-99.1
6przzmv 6ag57ztm5kt
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
8-K
t08w6sz3ky96lfco1o
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
DEFA14A
7hgda04c38
15 Oct 20
Additional proxy soliciting materials
7:20am
8-K
EX-99.1
2sdquhqyhxmh
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
8-K
paary
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
8-K
EX-10.1
h1pljljyciibmyiyi
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
8-K
EX-99.1
p4e5l36 9gb7xnblpyig
10 Sep 20
Myriad Genetics Expands Board of Directors with New Member
7:24am
8-K
EX-99.1
ehjk3hilsj 0ynarghw
14 Aug 20
Myriad Genetics Announces Inducement Awards
4:18pm
S-8
EX-99.1
jsmwxwja
14 Aug 20
Registration of securities for employees
12:00am
S-8
EX-99.4
zo86jo4u2 qxh
14 Aug 20
Registration of securities for employees
12:00am
S-8
EX-99.2
asnlgh 72fcx9t8zrco5
14 Aug 20
Registration of securities for employees
12:00am
S-8
EX-99.3
fzm7ojiu
14 Aug 20
Registration of securities for employees
12:00am
8-K
EX-99.1
7kt4okok63
13 Aug 20
Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer
4:26pm
8-K
dge1odcg5xjzc86
13 Aug 20
Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results
4:15pm
8-K
EX-99.1
x56ii5yyvo47b
13 Aug 20
Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results
4:15pm
8-K
EX-99.1
7in9ap59bx l6
22 Jul 20
Departure of Directors or Certain Officers
7:15am